<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0955">
 <label>191</label>
 <element-citation publication-type="journal" id="rf0950">
  <person-group person-group-type="author">
   <name>
    <surname>Sancho-Saldaña</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lambea-Gil</surname>
    <given-names>Á.</given-names>
   </name>
   <name>
    <surname>Liesa</surname>
    <given-names>J.L.C.</given-names>
   </name>
   <name>
    <surname>Caballo</surname>
    <given-names>M.R.B.</given-names>
   </name>
   <name>
    <surname>Garay</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Celada</surname>
    <given-names>D.R.</given-names>
   </name>
  </person-group>
  <article-title>Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection</article-title>
  <source>Clin Med (Lond).</source>
  <volume>20</volume>
  <issue>4</issue>
  <year>2020 Jul</year>
  <fpage>e93</fpage>
  <lpage>e94</lpage>
  <pub-id pub-id-type="doi">10.7861/clinmed.2020-0213</pub-id>
  <comment>clinmed.2020-0213</comment>
  <pub-id pub-id-type="pmid">32518103</pub-id>
 </element-citation>
</ref>
